Other Income/Expenses (Net)

$25.27M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$25.27Mperiod endingJun 30, 2026

CLDX Other Income/Expenses (Net) ($1.60M → $25.27M)

Annual Other Income/Expenses (Net)

High-resolution chart · PNG

CLDX other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period ending	Other Income/Expenses (Net) (USD)
Dec 31, 2025	28,600,000
Dec 31, 2024	37,215,000
Dec 31, 2023	13,113,000
Dec 31, 2022	2,909,000
Dec 31, 2021	505,000
Dec 31, 2020	2,407,000
Dec 31, 2019	4,153,000
Dec 31, 2018	4,487,000
Dec 31, 2017	4,214,000
Dec 31, 2016	4,386,000
Dec 31, 2015	2,344,000
Dec 31, 2014	4,350,000
Dec 31, 2013	-108,000
Dec 31, 2012	-1,046,000
Dec 31, 2011	-1,400,000
Dec 31, 2010	3,922,000
Dec 31, 2009	-4,200,000
Dec 31, 2008	-13,500,491
Dec 31, 2007	1,096,200
Dec 31, 2006	2,113,327
Dec 31, 2005	768,448
Dec 31, 2004	378,600
Dec 31, 2003	239,800
Dec 31, 2002	602,700
Dec 31, 2001	1,808,400
Dec 31, 2000	-6,534,200
Dec 31, 1999	635,200
Dec 31, 1998	49,600
Dec 31, 1997	-5,500,000
Dec 31, 1996	1,000,000
Dec 31, 1995	3,600,000
Dec 31, 1994	-2,100,000
Dec 31, 1993	1,200,000
Dec 31, 1992	800,000
Apr 30, 1992	3,000,000
Apr 30, 1990	3,300,000
Apr 30, 1989	1,000,000
Apr 30, 1988	800,000
Apr 30, 1987	0
Apr 30, 1986	1,600,000